Nyrada Inc. (ASX:NYR) ARBN 625 401 818 Annual report Building the future of TRPC-based therapeutics For the year ended 30 June 2026 NYRADA INC. (ASX:NYR) 2 The 2026 financial year was the year that turned Nyrada’s ambitions into clinical reality ...
Annual Report for year ended 30 June 2026
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nyrada
- Preliminary Final Report
- Appendix 4G and Corporate Governance Statement
- Change in substantial holding - M Azzi
- CSANZ26 Conference Poster
Later from Nyrada
- Nyrada Full Year Results FY2026
- Xolatryp Demonstrates Cardioprotection in Preclinical Study
- Application for quotation of securities - NYR
- Cleansing Statement
- Investor Presentation- Evans&Partners Small Cap Healthcare
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada